Human HMW Urokinase Reference 12-7-14

Posted by Leanne Kodsman on

Innovative Research's Human HMW Urokinase was recently used in the following study:

Conditionally activating optical contrast agent with enhanced sensitivity via gold nanoparticle plasmon energy transfer: feasibility study

KA Kang, J Wang - Journal of Nanobiotechnology, 2014
Urokinase-type plasminogen activator (uPA) was purchased from Innovative Research (Novi, MI). The ring-shaped spacer (rSP) was provided by Abgent (San Diego, CA) through customized synthesis.

Share this post


Related Posts

Immune reactivity against a variety of mammalian milks and plant-based milk substitutes
Single Donor Human Serum from Innovative Research was recently used in the following st...
Read the Article
Effect of CYP2C9 Polymorphisms on the Pharmacokinetics of Indomethacin During Pregnancy
Pooled Normal Human Plasma from Innovative Research was recently used in the following ...
Read the Article

← Older Post Newer Post →